David Chiswell, Kymab’s Chairman, takes over as interim CEO of Kymab until a new, permanent CEO is appointed.
Dr Christian Grøndahl will step down as Chief Executive Officer of Kymab with immediate effect because of family commitments.
"On behalf of the Board of Directors, I would like to thank Christian for his significant contribution to Kymab," commented Dr David Chiswell, Chairman and interim CEO of Kymab. "Under his leadership, the company has successfully raised $40m in a second funding round from two of the world’s largest foundations, the Wellcome Trust and The Bill and Melinda Gates Foundation, providing a strong foundation on which Kymab can enter its next stage of growth. We wish him every success in his next venture.
"We look forward to continuing the implementation of Kymab's strategy in building a substantial global biopharmaceutical company."